Navigating the GLP-1 Medication Landscape in America: A Comprehensive GuideThe pharmaceutical landscape in the United States has actually undergone a seismic shift over the last few years, driven mainly by the stratospheric rise of GLP-1 (Glucagon-like peptide-1) receptor agonists. Originally developed to manage Type 2 diabetes, these medications-- consisting of
